UPXI Market Analysis

Wall Street coverage

third-party context

Wall Street coverage

$1.30median target· current $0.76 (+72.0%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

News & Sentiment

49 articles · sorted by date
Page 1 of 3 · 49 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio1.43Forward 0.91
EPS (TTM)$0.533573.0% YoY
Profit margin0.0%COMMUNICATION SERVICES
Market cap$55.5MMicro cap

Valuation

Forward P/E
0.91
PEG ratio
P/B
1.85
P/S (TTM)
2.12
EV/EBITDA
4.54

Profitability & growth

ROE (TTM)
-468.5%
Operating margin
-2343.0%
Revenue growth YoY
44.2%
Dividend yield
Beta
-0.27
Last earnings
May 12, 2026 · Estimate $-0.20 · Reported $-1.67
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Upexi Inc.

Company profile

Grove, Inc., is engaged in the development, production, marketing, and sale of raw materials, private label products, and end-consumer products containing the industrial hemp plant extract, cannabidiol. The company is headquartered in Henderson, Nevada.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
3030 NORTH ROCKY POINT DRIVE, TAMPA, FL
Fiscal year end
June
Latest quarter
Mar 31, 2026
Market cap$55.5M
Shares outstanding$73.5M
52W high$9.12
52W low$0.54

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer